1. Home
  2. ABSI

as of 11-28-2025 12:40pm EST

$3.18
+$0.08
+2.75%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Chart Type:
Time Range:
Founded: 2011 Country:
United States
United States
Employees: N/A City: VANCOUVER
Market Cap: 461.6M IPO Year: 2021
Target Price: $7.78 AVG Volume (30 days): 4.6M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.90 EPS Growth: N/A
52 Week Low/High: $2.01 - $6.33 Next Earning Date: 11-12-2025
Revenue: $2,815,000 Revenue Growth: -33.09%
Revenue Growth (this year): 40.12% Revenue Growth (next year): 331.37%

AI-Powered ABSI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 74.50%
74.50%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Absci Corporation (ABSI)

Buy
ABSI Sep 22, 2025

Avg Cost/Share

$2.70

Shares

10,000

Total Value

$27,000.00

Owned After

180,428

SEC Form 4

ABSI Sep 22, 2025

Avg Cost/Share

$2.66

Shares

95,785

Total Value

$254,788.10

Owned After

113,960

SEC Form 4

Share on Social Networks: